Tuesday , April 24 2018
Home / Resources / Videos (page 61)

Videos

We have videos from AACE, ADA, and AADE that feature the speakers from those events. You will be the first to learn about the breakthroughs in diabetes care. You will also hear about interesting research projects that our featured diabetes experts are leading.

Szilard Voros, MD, Q10: Does the DPMP include CV data?

Szilard Voros, MD, talks about the three factors that are included in the DPMP test and how they overlap but are separate from the CV data reports. Other videos with Dr. Voros: Szilard Voros, MD, FACC, FSCCT, FAHA: Introduction New Panel of Tests (DPMP) Identifies Diabetes and CV Risk Earlier …

Read More »

Szilard Voros, MD: SGLT2 Inhibitors

Szilard_Voris

  Szilard Voros, MD, discusses what he found the most interesting at the 2013 ADA and singles out the new SGLT2 inhibitor class of drugs as especially exciting. However, he cautions that they are very new and only time will tell regarding any safety aspects. He is intrigued by the concept …

Read More »

Cyrus Desouza, MBBS, Introduction

Dr. Cyrus Desouza, MBBS, tells us a little about himself and talks about his work investigating the relationship between cardiovascular disease and diabetes. He is particularly interested in how diabetes drugs affect the cardiovascular system.

Read More »

Cyrus Desouza, MBBS: Status of TZD’s including Avandia

Cyrus_Desouza

Dr. Cyrus Desouza, MBBS, addresses the controversy around TZD’s especially Avandia. He notes that the initial research in animal models seemed to preserve beta function, raised adiponectin levels, improved endothelial function,and showed beneficial effects on BP. Hoever, with pioglitazone, a debate began on whether they were protective or not because of a retrospective study. …

Read More »

Cyrus Desouza, MBBS, Q3: Pros and Cons of Prescribing Actos

Dr. Cyrus Desouza, MBBS, discusses why he prescribes Actos, a thiazolidinedione. But he says there are some issues with this kind of drug, particularly weight gain. He does not prescribe actos to patients with high BMI’s and is also cautious because of bladder cancer concerns. Many patients are aware of these issues …

Read More »

Cyrus Desouza, MBBS: Prescribing SGLT2s

Cyrus_Desouza

Dr. Cyrus Desouza, MBBS, talks about why he is waiting a little longer before regularly prescribing sodium glucose cotransporter 2 (SGLT2) inhibitors. As an endocrinologist, he feels that, because he deals with very ill patients, it is incumbent upon him that he must also be more careful using a new drug.

Read More »